{"id":3707,"date":"2023-11-13T03:12:14","date_gmt":"2023-11-13T03:12:14","guid":{"rendered":"https:\/\/growingstronger.org\/?page_id=3707"},"modified":"2023-11-13T03:19:58","modified_gmt":"2023-11-13T03:19:58","slug":"tyra-biosciences","status":"publish","type":"page","link":"https:\/\/growingstronger.org\/ur\/tyra-biosciences\/","title":{"rendered":"Tyra Biosciences"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"3707\" class=\"elementor elementor-3707\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-975cdeb elementor-section-full_width events-banner elementor-section-height-default elementor-section-height-default\" data-id=\"975cdeb\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-8db195b\" data-id=\"8db195b\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-6c076cd events-inner elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6c076cd\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-c126972\" data-id=\"c126972\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f05c11b events-banner elementor-widget elementor-widget-heading\" data-id=\"f05c11b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Tyra Biosciences<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<div class=\"elementor-element elementor-element-bbdb2e8 elementor-widget elementor-widget-image\" data-id=\"bbdb2e8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1920\" height=\"154\" src=\"https:\/\/growingstronger.org\/wp-content\/uploads\/2022\/02\/site-banner-bg.png\" class=\"attachment-full size-full wp-image-1308\" alt=\"site-banner-bg\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-a5b23a2 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"a5b23a2\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3f55a7c\" data-id=\"3f55a7c\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-7811297 elementor-widget elementor-widget-text-editor\" data-id=\"7811297\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"http:\/\/tyra.bio\/\"><u>Tyra Biosciences, Inc.<\/u><\/a>&nbsp;is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptors (FGFR) biology. The Company\u2019s in-house precision medicine platform, SN\u00c5P, enables the rapid and precise refinement of structural drug design through iterative molecular SN\u00c5Pshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA\u2019s initial focus is on applying its accelerated small molecule drug discovery engine to develop therapies in targeted oncology and genetically defined conditions. TYRA is based in&nbsp;Carlsbad, CA.&nbsp;For more information about our science, pipeline and people, please visit&nbsp;<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3796792-1&amp;h=3545390080&amp;u=http%3A%2F%2Fwww.tyra.bio%2F&amp;a=www.tyra.bio\" target=\"_blank\" rel=\"noreferrer noopener\"><u>www.tyra.bio<\/u><\/a>&nbsp;and engage with them on&nbsp;<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3796792-1&amp;h=2668042379&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Ftyra-biosciences%2F%3FviewAsMember%3Dtrue&amp;a=LinkedIn\" target=\"_blank\" rel=\"noreferrer noopener\"><u>LinkedIn<\/u><\/a>.<\/p><p><br><\/p>\n<p><\/p>\n<p class=\"has-text-align-justify\">On March 1, 2023, TYRA&nbsp;<a href=\"https:\/\/tyrabio.investorroom.com\/2023-03-01-Tyra-Biosciences-Expands-Development-of-TYRA-300,-an-Oral-FGFR3-Selective-Agent,-into-Achondroplasia\" data-type=\"post\" data-id=\"6234\"><u>announced<\/u><\/a>&nbsp;their expanding development of TYRA-300, an oral FGFR3 selective agent, into achondroplasia (ACH) based on positive preclinical results demonstrated in a study performed in collaboration with the Imagine Institute in&nbsp;Paris, France. Achondroplasia, the most common form of dwarfism, is a skeletal dysplasia in which growth plate cartilage is affected, resulting in decreased growth of the long bones, vertebral bodies, and skull base.<\/p>\n<p>leo.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Tyra Biosciences Tyra Biosciences, Inc.&nbsp;is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptors (FGFR) biology. The Company\u2019s in-house precision medicine platform, SN\u00c5P, enables the rapid and precise refinement of structural drug design through iterative molecular SN\u00c5Pshots that help predict genetic alterations most likely to [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3707","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/growingstronger.org\/ur\/wp-json\/wp\/v2\/pages\/3707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/growingstronger.org\/ur\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/growingstronger.org\/ur\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/growingstronger.org\/ur\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/growingstronger.org\/ur\/wp-json\/wp\/v2\/comments?post=3707"}],"version-history":[{"count":4,"href":"https:\/\/growingstronger.org\/ur\/wp-json\/wp\/v2\/pages\/3707\/revisions"}],"predecessor-version":[{"id":3711,"href":"https:\/\/growingstronger.org\/ur\/wp-json\/wp\/v2\/pages\/3707\/revisions\/3711"}],"wp:attachment":[{"href":"https:\/\/growingstronger.org\/ur\/wp-json\/wp\/v2\/media?parent=3707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}